This system was employed in conjunction with light-activated chemotherapy and RNA interference (RNAi) to treat platinum-resistant ovarian cancer.902 CNPPtCP/si(c-fos) can produce oxygen-independent N3• with slight oxidation energy under blue light (430 nm) irradiation. The gene discussed is FOS; the disease is ovarian carcinoma.